作者：
Nikhil C,Munshi [1]
;
Larry D,Anderson [1]
;
Nina,Shah [1]
;
Deepu,Madduri [1]
;
Jesús,Berdeja [1]
;
Sagar,Lonial [1]
;
Noopur,Raje [1]
;
Yi,Lin [1]
;
David,Siegel [1]
;
Albert,Oriol [1]
;
Philippe,Moreau [1]
;
Ibrahim,Yakoub-Agha [1]
;
Michel,Delforge [1]
;
Michele,Cavo [1]
;
Hermann,Einsele [1]
;
Hartmut,Goldschmidt [1]
;
Katja,Weisel [1]
;
Alessandro,Rambaldi [1]
;
Donna,Reece [1]
;
Fabio,Petrocca [1]
;
Monica,Massaro [1]
;
Jamie N,Connarn [1]
;
Shari,Kaiser [1]
;
Payal,Patel [1]
;
Liping,Huang [1]
;
Timothy B,Campbell [1]
;
Kristen,Hege [1]
;
Jesús,San-Miguel [1]
作者单位：
From the Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute (N.C.M.), the Veterans Affairs Boston Healthcare System, Harvard Medical School (N.C.M.), and Massachusetts General Hospital (N.R.), Boston, and bluebird bio, Cambridge (F.P., M.M.) - all in Massachusetts; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas (L.D.A.); the University of California, San Francisco, San Francisco (N.S.); Icahn School of Medicine at Mount Sinai, New York (D.M.); Sarah Cannon Research Institute and Tennessee Oncology, Nashville (J.B.); Emory School of Medicine, Atlanta (S.L.); Mayo Clinic, Rochester, MN (Y.L.); Hackensack University Medical Center, Hackensack (D.S.), and Bristol-Myers Squibb, Princeton (J.N.C., S.K., P.P., L.H., T.B.C., K.H.) - both in New Jersey; Institut Josep Carreras and Institut Catala d'Oncologia, Hospital Germans Trias i Pujol, Badalona (A.O.), and Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona (J.S.-M.) - both in Spain; Centre Hospitalier Universitaire (CHU) de Nantes, Nantes (P.M.), and CHU de Lille, University of Lille, INSERM Unité 1286, Institute for Translational Research in Inflammation, Lille (I.Y.-A.) - both in France; University Hospital Leuven, Leuven, Belgium (M.D.); "Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna (M.C.), the Department of Oncology and Hematology, University of Milan, Milan (A.R.), and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo (A.R.) - all in Italy; University Hospital of Würzburg, Würzburg (H.E.), University Hospital Heidelberg (H.G.) and the National Center for Tumor Diseases (H.G.), Heidelberg, the University Medical Center Hamburg-Eppendorf, Hamburg (K.W.), and Universitätsklinikum Tübingen, Tübingen (K.W.) - all in Germany; and Princess Margaret Cancer Centre, Toronto (D.R.).
[1]
DOI
10.1056/NEJMoa2024850
PMID
33626253
发布时间
2021-06-17
换一批
换一批
